Ieq Capital »

Intellia Therapeutics shares owned by Ieq Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Ieq Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $370k 21k 17.27
2025-03-31 $82k 12k 7.11

More positions owned by Ieq Capital

Applovin Corp Com Cl A (APP)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Crowdstrike Hldgs Cl A (CRWD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Snowflake Com Shs (SNOW)

View all positions for Ieq Capital

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics